Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Sep 1;100(5):1166–1173. doi: 10.1172/JCI119628

Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

E Ferrannini 1, A Natali 1, P Bell 1, P Cavallo-Perin 1, N Lalic 1, G Mingrone 1
PMCID: PMC508292  PMID: 9303923

Abstract

Insulin resistance and insulin hypersecretion are established features of obesity. Their prevalence, however, has only been inferred from plasma insulin concentrations. We measured insulin sensitivity (as the whole-body insulin-mediated glucose uptake) and fasting posthepatic insulin delivery rate (IDR) with the use of the euglycemic insulin clamp technique in a large group of obese subjects in the database of the European Group for the Study of Insulin Resistance (1,146 nondiabetic, normotensive Caucasian men and women aged 18-85 yr, with a body mass index (BMI) ranging from 15 to 55 kg.m-2). Insulin resistance, defined as the lowest decile of insulin sensitivity in the lean subgroup (608 subjects with a mean BMI of 29 kg.m-2). Insulin sensitivity declined linearly with BMI at an age- and sex-adjusted rate of 1.2 micromol.min-1.kg FFM-1 per BMI unit (95% confidence intervals = 1.0-1.4). Insulin hypersecretion, defined as the upper decile of IDR, was significantly (P<0.0001) more prevalent (38%) than insulin resistance in the obese group. In the whole dataset, IDR rose as a function of both BMI and insulin resistance in a nonlinear fashion. Neither the waist circumference nor the waist-to-hip ratio, indices of body fat distribution, was related to insulin sensitivity after adjustment for age, gender, and BMI; both, however, were positively associated (P<0.001) with insulin hypersecretion, particularly in women. In nondiabetic, normotensive obese subjects, the prevalence of insulin resistance is relatively low, and is exceeded by the prevalence of insulin hypersecretion, particularly in women with central obesity. In the obese with preserved insulin sensitivity, risk for diabetes, cardiovascular risk, and response to treatment may be different than in insulin resistant obesity.

Full Text

The Full Text of this article is available as a PDF (234.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Björntorp P. Abdominal obesity and the development of noninsulin-dependent diabetes mellitus. Diabetes Metab Rev. 1988 Sep;4(6):615–622. doi: 10.1002/dmr.5610040607. [DOI] [PubMed] [Google Scholar]
  2. Bogardus C., Lillioja S., Mott D., Reaven G. R., Kashiwagi A., Foley J. E. Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians. J Clin Invest. 1984 Mar;73(3):800–805. doi: 10.1172/JCI111274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bonadonna R. C., Groop L., Kraemer N., Ferrannini E., Del Prato S., DeFronzo R. A. Obesity and insulin resistance in humans: a dose-response study. Metabolism. 1990 May;39(5):452–459. doi: 10.1016/0026-0495(90)90002-t. [DOI] [PubMed] [Google Scholar]
  4. Bonora E., Del Prato S., Bonadonna R. C., Gulli G., Solini A., Shank M. L., Ghiatas A. A., Lancaster J. L., Kilcoyne R. F., Alyassin A. M. Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes. 1992 Sep;41(9):1151–1159. [PubMed] [Google Scholar]
  5. Brindley D. N., Rolland Y. Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis. Clin Sci (Lond) 1989 Nov;77(5):453–461. doi: 10.1042/cs0770453. [DOI] [PubMed] [Google Scholar]
  6. Castillo M. J., Scheen A. J., Letiexhe M. R., Lefèbvre P. J. How to measure insulin clearance. Diabetes Metab Rev. 1994 Jul;10(2):119–150. doi: 10.1002/dmr.5610100205. [DOI] [PubMed] [Google Scholar]
  7. DeFronzo R. A., Tobin J. D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979 Sep;237(3):E214–E223. doi: 10.1152/ajpendo.1979.237.3.E214. [DOI] [PubMed] [Google Scholar]
  8. Defronzo R. A. Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes. 1979 Dec;28(12):1095–1101. doi: 10.2337/diab.28.12.1095. [DOI] [PubMed] [Google Scholar]
  9. Després J. P., Lamarche B., Mauriège P., Cantin B., Dagenais G. R., Moorjani S., Lupien P. J. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996 Apr 11;334(15):952–957. doi: 10.1056/NEJM199604113341504. [DOI] [PubMed] [Google Scholar]
  10. Evans D. J., Hoffmann R. G., Kalkhoff R. K., Kissebah A. H. Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism. 1984 Jan;33(1):68–75. doi: 10.1016/0026-0495(84)90164-1. [DOI] [PubMed] [Google Scholar]
  11. Ferrannini E., Buzzigoli G., Bonadonna R., Giorico M. A., Oleggini M., Graziadei L., Pedrinelli R., Brandi L., Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987 Aug 6;317(6):350–357. doi: 10.1056/NEJM198708063170605. [DOI] [PubMed] [Google Scholar]
  12. Ferrannini E., Cobelli C. The kinetics of insulin in man. I. General aspects. Diabetes Metab Rev. 1987 Apr;3(2):335–363. doi: 10.1002/dmr.5610030201. [DOI] [PubMed] [Google Scholar]
  13. Ferrannini E., Cobelli C. The kinetics of insulin in man. II. Role of the liver. Diabetes Metab Rev. 1987 Apr;3(2):365–397. doi: 10.1002/dmr.5610030202. [DOI] [PubMed] [Google Scholar]
  14. Ferrannini E., Haffner S. M., Stern M. P., Mitchell B. D., Natali A., Hazuda H. P., Patterson J. K. High blood pressure and insulin resistance: influence of ethnic background. Eur J Clin Invest. 1991 Jun;21(3):280–287. doi: 10.1111/j.1365-2362.1991.tb01371.x. [DOI] [PubMed] [Google Scholar]
  15. Ferrannini E., Pilo A. Pattern of insulin delivery after intravenous glucose injection in man and its relation to plasma glucose disappearance. J Clin Invest. 1979 Jul;64(1):243–254. doi: 10.1172/JCI109445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ferrannini E., Vichi S., Beck-Nielsen H., Laakso M., Paolisso G., Smith U. Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes. 1996 Jul;45(7):947–953. doi: 10.2337/diab.45.7.947. [DOI] [PubMed] [Google Scholar]
  17. Ferrannini E., Wahren J., Faber O. K., Felig P., Binder C., DeFronzo R. A. Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am J Physiol. 1983 Jun;244(6):E517–E527. doi: 10.1152/ajpendo.1983.244.6.E517. [DOI] [PubMed] [Google Scholar]
  18. Flatt J. P. Importance of nutrient balance in body weight regulation. Diabetes Metab Rev. 1988 Sep;4(6):571–581. doi: 10.1002/dmr.5610040603. [DOI] [PubMed] [Google Scholar]
  19. Fontbonne A., Tchobroutsky G., Eschwege E., Richards J. L., Claude J. R., Rosselin G. E. Coronary heart disease mortality risk: plasma insulin level is a more sensitive marker than hypertension or abnormal glucose tolerance in overweight males. The Paris Prospective Study. Int J Obes. 1988;12(6):557–565. [PubMed] [Google Scholar]
  20. Fulcher G. R., Farrer M., Walker M., Rodham D., Clayton B., Alberti K. M. A comparison of measurements of lean body mass derived by bioelectrical impedance, skinfold thickness and total body potassium. A study in obese and non-obese normal subjects. Scand J Clin Lab Invest. 1991 May;51(3):245–253. doi: 10.3109/00365519109091611. [DOI] [PubMed] [Google Scholar]
  21. Hollenbeck C. B., Chen Y. D., Reaven G. M. A comparison of the relative effects of obesity and non-insulin-dependent diabetes mellitus on in vivo insulin-stimulated glucose utilization. Diabetes. 1984 Jul;33(7):622–626. doi: 10.2337/diab.33.7.622. [DOI] [PubMed] [Google Scholar]
  22. Hume R. Prediction of lean body mass from height and weight. J Clin Pathol. 1966 Jul;19(4):389–391. doi: 10.1136/jcp.19.4.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Jeanrenaud B. Neuroendocrine and metabolic basis of type II diabetes as studied in animal models. Diabetes Metab Rev. 1988 Sep;4(6):603–614. doi: 10.1002/dmr.5610040606. [DOI] [PubMed] [Google Scholar]
  24. Kahn S. E., Prigeon R. L., McCulloch D. K., Boyko E. J., Bergman R. N., Schwartz M. W., Neifing J. L., Ward W. K., Beard J. C., Palmer J. P. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993 Nov;42(11):1663–1672. doi: 10.2337/diab.42.11.1663. [DOI] [PubMed] [Google Scholar]
  25. Kissebah A. H., Krakower G. R. Regional adiposity and morbidity. Physiol Rev. 1994 Oct;74(4):761–811. doi: 10.1152/physrev.1994.74.4.761. [DOI] [PubMed] [Google Scholar]
  26. Kolterman O. G., Insel J., Saekow M., Olefsky J. M. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest. 1980 Jun;65(6):1272–1284. doi: 10.1172/JCI109790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Krotkiewski M., Björntorp P., Sjöström L., Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest. 1983 Sep;72(3):1150–1162. doi: 10.1172/JCI111040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kuczmarski R. J., Flegal K. M., Campbell S. M., Johnson C. L. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA. 1994 Jul 20;272(3):205–211. doi: 10.1001/jama.272.3.205. [DOI] [PubMed] [Google Scholar]
  29. Lillioja S., Mott D. M., Howard B. V., Bennett P. H., Yki-Järvinen H., Freymond D., Nyomba B. L., Zurlo F., Swinburn B., Bogardus C. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med. 1988 May 12;318(19):1217–1225. doi: 10.1056/NEJM198805123181901. [DOI] [PubMed] [Google Scholar]
  30. Manson J. E., Colditz G. A., Stampfer M. J., Willett W. C., Rosner B., Monson R. R., Speizer F. E., Hennekens C. H. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 1990 Mar 29;322(13):882–889. doi: 10.1056/NEJM199003293221303. [DOI] [PubMed] [Google Scholar]
  31. Modan M., Karasik A., Halkin H., Fuchs Z., Lusky A., Shitrit A., Modan B. Effect of past and concurrent body mass index on prevalence of glucose intolerance and type 2 (non-insulin-dependent) diabetes and on insulin response. The Israel study of glucose intolerance, obesity and hypertension. Diabetologia. 1986 Feb;29(2):82–89. doi: 10.1007/BF00456115. [DOI] [PubMed] [Google Scholar]
  32. Navalesi R., Pilo A., Ferrannini E. Kinetic analysis of plasma insulin disappearance in nonketotic diabetic patients and in normal subjects. A tracer study with 125I-insulin. J Clin Invest. 1978 Jan;61(1):197–208. doi: 10.1172/JCI108918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Ohlson L. O., Larsson B., Svärdsudd K., Welin L., Eriksson H., Wilhelmsen L., Björntorp P., Tibblin G. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes. 1985 Oct;34(10):1055–1058. doi: 10.2337/diab.34.10.1055. [DOI] [PubMed] [Google Scholar]
  34. Pasquali R., Casimirri F., Cantobelli S., Melchionda N., Morselli Labate A. M., Fabbri R., Capelli M., Bortoluzzi L. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism. 1991 Jan;40(1):101–104. doi: 10.1016/0026-0495(91)90199-7. [DOI] [PubMed] [Google Scholar]
  35. Pedersen S. B., Børglum J. D., Schmitz O., Bak J. F., Sørensen N. S., Richelsen B. Abdominal obesity is associated with insulin resistance and reduced glycogen synthetase activity in skeletal muscle. Metabolism. 1993 Aug;42(8):998–1005. doi: 10.1016/0026-0495(93)90013-e. [DOI] [PubMed] [Google Scholar]
  36. Peiris A. N., Mueller R. A., Smith G. A., Struve M. F., Kissebah A. H. Splanchnic insulin metabolism in obesity. Influence of body fat distribution. J Clin Invest. 1986 Dec;78(6):1648–1657. doi: 10.1172/JCI112758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Polonsky K. S., Given B. D., Hirsch L. J., Tillil H., Shapiro E. T., Beebe C., Frank B. H., Galloway J. A., Van Cauter E. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med. 1988 May 12;318(19):1231–1239. doi: 10.1056/NEJM198805123181903. [DOI] [PubMed] [Google Scholar]
  38. Polonsky K. S., Given B. D., Van Cauter E. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest. 1988 Feb;81(2):442–448. doi: 10.1172/JCI113339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Pyörälä K. Hyperinsulinaemia as predictor of atherosclerotic vascular disease: epidemiological evidence. Diabete Metab. 1991 May;17(1 Pt 2):87–92. [PubMed] [Google Scholar]
  40. RABINOWITZ D., ZIERLER K. L. Forearm metabolism in obesity and its response to intra-arterial insulin. Characterization of insulin resistance and evidence for adaptive hyperinsulinism. J Clin Invest. 1962 Dec;41:2173–2181. doi: 10.1172/JCI104676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Reaven G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988 Dec;37(12):1595–1607. doi: 10.2337/diab.37.12.1595. [DOI] [PubMed] [Google Scholar]
  42. Robert J. J., Cummins J. C., Wolfe R. R., Durkot M., Matthews D. E., Zhao X. H., Bier D. M., Young V. R. Quantitative aspects of glucose production and metabolism in healthy elderly subjects. Diabetes. 1982 Mar;31(3):203–211. doi: 10.2337/diab.31.3.203. [DOI] [PubMed] [Google Scholar]
  43. Schwartz M. W., Figlewicz D. P., Baskin D. G., Woods S. C., Porte D., Jr Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev. 1992 Aug;13(3):387–414. doi: 10.1210/edrv-13-3-387. [DOI] [PubMed] [Google Scholar]
  44. Shulman G. I., Rothman D. L., Jue T., Stein P., DeFronzo R. A., Shulman R. G. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med. 1990 Jan 25;322(4):223–228. doi: 10.1056/NEJM199001253220403. [DOI] [PubMed] [Google Scholar]
  45. Swinburn B. A., Nyomba B. L., Saad M. F., Zurlo F., Raz I., Knowler W. C., Lillioja S., Bogardus C., Ravussin E. Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest. 1991 Jul;88(1):168–173. doi: 10.1172/JCI115274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Webber J., Donaldson M., Allison S. P., Fukagawa N. K., Macdonald I. A. The effects of weight loss in obese subjects on the thermogenic, metabolic and haemodynamic responses to the glucose clamp. Int J Obes Relat Metab Disord. 1994 Nov;18(11):725–730. [PubMed] [Google Scholar]
  47. Welborn T. A., Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 1979 Mar-Apr;2(2):154–160. doi: 10.2337/diacare.2.2.154. [DOI] [PubMed] [Google Scholar]
  48. Wingard D. L., Barrett-Connor E. L., Ferrara A. Is insulin really a heart disease risk factor. Diabetes Care. 1995 Sep;18(9):1299–1304. doi: 10.2337/diacare.18.9.1299. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES